Future Horizons in the Global Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Country

Published: August 2012
No. of Pages: 1200
Original Price: US $ 28500
   

Highlights

  • Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years
  • Examines trends in the U.S., Europe and Japan
  • Reviews current and emerging tumor markers
  • Analyzes applications of emerging diagnostic technologies
  • Forecasts sales of major tumor markers by country and market segment
  • Profiles leading market players and potential entrants
  • Suggests alternative business expansion strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Coverage

  • France
  • Germany
  • Italy
  • Japan
  • Spain
  • UK
  • USA

Market Segmentation Analysis

  • Sales and market shares of major suppliers, by individual tumor marker and country.
  • Ten-year test volume and sales forecasts for major tumor markers by country and market segment, including:
    • Hospitals
    • Commercial/Private Laboratories
    • Physician Offices/Group Practices
    • Cancer Clinics
    • Ambulatory Care Centers
  • Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.
  • Cancer statistics, etiology and recent developments in the U.S., Japan and five major European countries.

Current and Emerging Products

  • Review of over 200 current and emerging tumor markers, including:
    • Biochemical Markers
    • Oncogenes
    • Growth Factors
    • Hormones
    • Colony Stimulating Factors
    • Lymphokines
    • Immunohistochemical Stains, and others.
  • Analysis of major immunoassay analyzers used for tumor marker testing, including their operating characteristics, features and selling prices.

Technology Review

  • Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and their potential applications for tumor marker testing.
  • Review of competing/complementing technologies, including CT, MRI, NMR, PET and photonics spectroscopy.
  • Extensive listings of over 500 companies, universities and research centers developing new tumor markers and detection technologies.


Competitive Assessments
Extensive strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Worldwide Market Overview

  • Estimated universe of laboratories performing tumor marker testing by country.
  • Ten-year test volume and sales projections by country.
  • Business Opportunities and Strategic Recommendations
  • Specific new product development opportunities with potentially significant market appeal during the next ten years.
  • Design criteria for new products.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.

Methodology

This report is based on interviews with clinical pathologists, laboratory directors, executives from leading diagnostic companies and start-up firms developing innovative products, university scientists, as well as experts from industry associations, venture capital firms and the investment banking community in the U.S., five major European countries and Japan.

The market projections are also based on questionnaire responses received from hospitals, commercial/private laboratories, physician offices/group practices, cancer clinics and ambulatory care centers in seven countries.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product literature, patents, trade association surveys, government studies, marketing and technical meeting presentations, industry analyst reports, and VPG's proprietary data files was conducted.

Contains: 1,200 pages and 450 tables.

Future Horizons in the Global Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Country

Table of Contents

Introduction

Worldwide Market and Technology Overview

A. Cancer Statistics and Etiology

1. Bladder
2. Breast
3. Cervical
4. Colon and Rectum
5. Endometrial
6. Esophagus
7. Head and Neck
8. Leukemia
9. Lung
10. Lymphoma
11. Oral
12. Ovarian
13. Prostate
14. Renal Cell Carcinoma
15. Skin
16. Stomach
17. Uterine

B. Major Current And Emerging Tumor Marker
1. Introduction
2. Tumor Marker Classification
3. ACTH
4. AlphaFetoprotein (AFP)
5. Beta2 Microglobulin
6. CA 153/27.29
7. CA 199
8. CA125
9. Calcitonin
10. Carcinoembrionic Antigen (CEA)
11. Estrogen and Progesterone Receptors
12. Ferritin
13. Gastrin
14. Human Chorionic Gonadotropin (HCG)
15. Insulin
16. Lymphocytes CD4/CD8
17. NSE
18. Occult Blood
19. PAP Smear/HPV
20. Prostatic Acid Phosphatase (PAP)
21. ProstateSpecific Antigen (PSA)
22. Squamous Cell Carcinoma Antigen (SCC)
23. TdT
24. Thyroglobulin
25. Tissue Polypeptide Antigen (TPA)
26. Biochemical Tumor Markers
ADA
BProtein
PNP
5'Nucleotidase
27. Oncogenes
Abl/ablbcr
AIB1
APC
BTA 26
BCL2
BCRABL
Braf
BRCA
CD44
CDK
Cabl
Cfos
Cmyb
Cmyc
CYCD1
CYP17
DPC
Emyc
ErbB
HER2/neu
HPC1
HSTF
Lmyc
MET
MSH
NEU
Nmyc
Ntelopeptide
PCA3
PIK3CA
PTI1
P10
P40
P51
P53
Ras
Reg
RET
sFas
Sis
Src
28. Polypeptide Growth Factors
Basic Fibroblast Growth Factor
BetaTGF
Cachectin (TNT)
Calmodulin
ECFR
Nerve Growth Factor (NGF)
Epidermal Growth Factor (EGF)
Ornithine Decarboxylase
Transferrin
Transforming Growth FactorAlpha
29. Ectopic Hormones
30. Colony Stimulating Factors
31. Lymphokines
AlphaInterferon
B Cell Growth Factors
B Cell Growth Factor (BCGF)
GammaInterferon
Interleukin1 (IL1)
Macrophage Activating Factor
32. Immunohistochemical Stains
33. Emerging Tumor Markers
NAcetylglucosamine
Actin
AlphaActin
Angiogenin
Angiostatin
Antineuronal Antibodies
7B2
B72.3
BProtein
Bax
BCDF9
BLCA4
Blood Group Antigens A,B,H
BTA
CA 50
CA 724/TAG72
CA 195
CA242
CA549
Cadherin
CAM 26
CAR3
CD105
CathepsinD
Chromogranin A and B
Cluster 1 Antigen
Cluster5/5A Antigen
COX Antigen
CTA
CU18
Cyclin
DR70
DUPAN2
Endometrial Bleeding Associated Factor
Endostatin
Epithelial Membrane Antigen
FDP
Feulgen Hydrolysis
Fibronectin
FSH
(1>3)Lfucosyltransferase
GastrinReleasing Peptide (GRP)
GDCFP15
Glucagon
Glycoamines
H23
HAAH
hk3
HPA
HSP27
Human Carcinoma Antigen
ICAM
Intermediate Filaments
Cytokeratins/CK18/Cyfra 211
Desmin
Gliofibrillary Acid Protein
Neurofilaments
Vimentin
KA 93
Kallikrein
Kinases
KP16D3
LAI
Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma 552
MABDF3
MAG
ME1
Minactivin
MN/CA9
MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor 1
Myosin
NEA130
NMP22
Nucleolar
OA519
Opiod Peptides
Pglycoprotein
Pancreatic Oncofetal Antigen (POA)
Parathyrcoid Hormone
Placental Lactogen
PR92
Proliferative Index, Ki67
Px
RB Inactivation/Deletion
Ret
S100 Protein
SCCL 175
Selectin
Serotonin
Sialic Acid
Sialyl SSEA1/SLX
SN10
Somatostatin
TA90
TABA
Tachykinin
TAG 12
TPS
Troponin
Tubulin
VCAM
VEGF
Villen
White Blood Cell Markers

C. Instrumentation Review And Market Needs
1. Abbott AxSYM
2. Abbott IMx
3. Anagen AN2000/AuraFlex
4. Beckman Coulter Access
5. BioChem Pharma SR1
6. bioMerieux Vidas Series
7. Biotrol Systems 7000
8. J&J Diagnostics/Amersham Amerlite
9. J&J Diagnostics Vitros ECI
10. Olympus PK Series
11. Roche Cobas Core
12. Roche Elecsys
13. Roche ES 22
14. Roche ES 33
15. Roche ES 300/300 AL
16. Siemens ACS: 180
17. Siemens ACS: Centaur
18. Siemens ELISA Processor II/III
19. Siemens Immuno 1
20. Siemens/Opus/Plus/Magnum
21. Siemens Stratus
22. Tosoh AIA Series
23. Wallac/Pharmacia Delfia

D. Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
Overview
ELISA
Immunofiltration
ParticleMembrane Capture Immunoassay
Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
Chemiluminescence
Bioluminescence
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
PCR
DAPPCR
ImmunoPCR
QCPCR
CAR
DNA
HPA
LCR
NASBA
QBR
SDA
3 SR, and others
4. Biochips/Microarrays
5. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas
Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
6. Microcomputers and Automation
7. Artificial Intelligence
8. Flow Cytometry
9. Biosensors

E. Competing/Complementing Technologies
1. CT
2. MRI
3. NMR
4. PET
5.Photonics Spectroscopy

F. Business Environment
1. Worldwide Market Structure
2. Worldwide Market Size and Growth

G. Personal Testing

France


A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

Germany

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

Italy

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

Japan

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

Spain

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

U.K.

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

U.S.A.

A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. HMO
b. PPO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
13. FDA Reform
C. Market Structure
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
2. POT/Decentralized Testing
a. Physician Offices/Group Practices
b. Cancer Clinics
c. Other Decentralized Testing Locations
D. Market Size, Growth and Major Suppliers Sales,
Instrument Placements and Market Shares

Major Product Development Opportunities

A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies


A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor

Potential Market Entry Barriers and Risks

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

Competitive Profiles

Abbott
AdnaGen
Ambrilia Biopharma
AMDL
Beckman Coulter
Becton Dickinson
Biomedical Diagnostics
bioMerieux
BioRad
CanAG Diagnostics
CeMines
Cepheid
Correlogic Systems
Dako
Decode
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
GenProbe
Guided Therapeutics
Hologic
Ipsogen
J&J Diagnostics
Kreatech
Kyowa Medex
Mackay Life Sciences
Matritech
Myriad Genetics
OncoLab
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Veridex
Wako Pure Chemicals
Wallac
Zila

Appendixes

Appendix I: Major Companies Developing or
Marketing Tumor Marker Reagents
and Instruments
Appendix II: Major Universities and Research
Centers Developing Tumor Marker
Detection
Technologies and Applications
Appendix III: Assumed Currency Exchange Rates

List of Tables

Tumor Marker Classification
Major Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta2 Microglobulin Tests
Major Companies Developing or Marketing
CA 153/27.29 Tests
Major Companies Developing or Marketing
CA 199 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests
Major Companies Developing or Marketing
HCG Tests
Major Companies Developing or Marketing
Insulin Tests
Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications
In Cancer Diagnosis
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: France, Total Tumor
Marker Test Volume and Sales Forecast by Market
Segment
France, Estimated Cancer Death Rates
Per 100,000 Population
France, Laboratories Performing Tumor
Marker Tests by Market Segment
France, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
France, Commercial/Private Laboratories
Performing Tumor Markers by Annual
Test Volume
France, Total Tumor Marker Volume
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Test Volume Forecast
France, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
France, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
France, Total Tumor Marker Sales Forecast
By Market Segment
France, All Market Segments Major Tumor
Marker Sales Forecast by Test
France, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
France, Commercial/Private Laboratories
Tumor Marker Market Forecast by Test
France, ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
France, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Beta2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
France, CA 153/27.29 Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, CA 199 Test Volume and Diagnostics
Sales Forecast by Market
France, CA125 Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, ColonSpecific Antigen Test Volume
And Diagnostics Sales Forecast by Market
Segment
France, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
France, Ferritin Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, HCG Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Interferons Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Interleukins Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Lymphocyte Subtyping Test Volume
And Diagnostics Sales Forecast by Market
Segment
France, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
France, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Parathyroid Hormone Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Progesterone Receptor Test Volume
And Diagnostics Sales Forecast by Market
Segment
France, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
France, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, S100 Protein Test Volume and Sales
Diagnostics Sales Forecast by Market
Segment
France, Serotonin Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
France, TDT Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Thymidine Kinase Test Volume
And Diagnostics Sales Forecast by
Market Segment
France, Thyroglobulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, TPA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Total Tumor Marker Sales
By Major Suppliers
France, AFP Testing Market Diagnostics
Sales by Major Supplier
France, CA 153 Testing Market Diagnostics
Sales by Major Supplier
France, CA 199 Testing Market Diagnostics
Sales by Major Supplier
France, CA 125 Testing Market Diagnostics
Sales by Major Supplier
France, CEA Testing Market Diagnostics
Sales by Major Supplier
France, NSE Testing Market Diagnostics
Sales by Major Supplier
France, PAP Testing Market Diagnostics
Sales by Major Supplier
France, PSA Testing Market Diagnostics
Sales by Major Supplier
France, Tumor Marker Testing
Instrumentation Major Systems
Estimated Placements and Installed
Base by Supplier and Model
Executive Summary Table: Germany, Total
Tumor Marker Test Volume and Sales Forecast
By Market Segment
Germany, Estimated Cancer Death Rates
Per 100,000 Population
Germany, Laboratories Performing Tumor
Marker Tests by Market Segment
Germany, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Germany, Commercial/Private Laboratories
Performing Tumor Marker Tests by Annual
Volume
Germany, Total Tumor Marker Test Volume
Forecast by Market Segment
Germany, All Market Segments, Major Tumor
Marker Test Volume Forecast
Germany, Hospital Laboratories, Major
Tumor Marker Test Volume Forecast by
Assay
Germany, Commercial/Private Laboratories
Major Tumor Marker Test Volume
Forecast
Germany, Physician Offices/Group
Practices Major Tumor Marker
Test Volume Forecast
Germany, Total Tumor Marker Sales
Forecast by Market Segment
Germany, All Market Segments Major Tumor
Marker Sales Forecast by Assay
Germany, Hospital Laboratories, Major Tumor
Marker Sales Forecast by Test
Germany, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
Germany, Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
Germany, ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Beta2 Microglobulin Test Volume
And Diagnostics Sales Forecast by Market
Segment
Germany, CA153/27.29 Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, CA19 Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, CA 125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Calcitonin Test Volume and
Diagnostic Sales Forecast by Market
Segment
Germany, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany, ColonSpecific Antigen Test Volume
And Diagnostics Sales Forecast by Market
Segment
Germany, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, HCG, Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Interferons Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Interleukins Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany, Pap Smear Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Parathyroid Hormone Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Progesterone Receptor Test Volume
And Diagnostics Sales Forecast by Market
Segment
Germany, PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, S100 Protein Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Serotonin Test Volume and
Diagnostics Sales Forecast by Mar
Segment
Germany, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Thymidine Kinase Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, Thyroglobulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Germany, TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Total Tumor Marker Sales
By Major Supplier
Germany, AFP Testing Market Diagnostics
Sales by Major Supplier
Germany CA 153/27.29 Testing Market
Diagnostics Sales by Major Supplier
Germany CA 199 Testing Market Diagnostics
Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Germany, CEA Testing Market Diagnostics
Sales by Major Supplier
Germany, PSA Testing Market Diagnostics
Sales by Major Supplier
Germany, Tumor Marker Testing
Instrumentation Major Systems
Estimated Placements and Installed Base
By Supplier and Model
Executive Summary Table: Italy, Total Tumor
Marker Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Estimated Cancer Death Rates
Per 100,000 Population
Italy, Laboratories Performing Tumor
Marker Tests by Market Segment
Italy, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Italy, Commercial/Private Laboratories
Performing Tumor Markers by Annual
Test Volume
Italy, Total Tumor Marker Test Volume
Forecast by Market Segment
Italy, All Market Segments Major Tumor Marker
Test Volume Forecast
Italy, Hospital Laboratories Major Tumor
Marker Test Volume Forecast
Italy, Commercial/Private Laboratories
Major Tumor Marker Test Volume
Forecast
Italy, Total Tumor Marker Market
Forecast by Market Segment
Italy, All Market Segments Major Tumor
Marker Sales Forecast by Test
Italy, Hospital Laboratories Major
Tumor Marker Forecast by Test
Italy, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by
Test
Italy, ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Beta2 Microglobulin Test Volume
And Diagnostics Sales Forecast by
Market Segment
Italy, CA 153/27.29 Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, CA199 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, CA 125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Colon Specific Antigen Test Volume
And Diagnostics Sales Forecast by Market
Segment
Italy, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Lymphocyte Subtyping Test Volume
And Diagnostics Sales Forecast by Market
Segment
Italy, NSE Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Occult Blood Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Oncogenes Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Pancreatic Oncofetal Antigen Test
Volume and Diagnostics Sales Forecast by
Market Segment
Italy, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, Parathyroid Hormone Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, Progesterone Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, S100 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Serotonin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, Squamous Cell Carcinoma Antigen Test
Volume and Diagnostics Sales Forecast by
Market Segment
Italy, TDT Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Thymidine Kinase Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, Thyroglobulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Italy, TPA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Total Tumor Markers
Sales by Major Supplier
Italy, AFP Testing Market Diagnostics
Sales by Major Supplier
Italy, CEA Testing Market Diagnostics
Sales by Major Supplier
Italy, PSA Testing Market Diagnostics
Sales by Major Supplier
Italy, Tumor Marker Testing Instrumentation
Major NonIsotopic Systems Estimated
Installed Base by Supplier and Model
Executive Summary Table: Japan, Total Tumor
Marker Test Volume and Sales Forecast by
Market Segment
Japan, Estimated Cancer Death Rates
Per 100,000 Population
Japan, Laboratories Performing Tumor
Marker Tests by Market Segment
Japan, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Commercial/Private Laboratories
Performing Tumor Marker Tests
By Annual Volume
Japan, Total Tumor Marker Test Volume
Forecast by Market Segment
Japan, All Market Segments Major Tumor
Marker Test Volume Forecast
Japan, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Assay
Japan, Commercial/Private Laboratories Major
Tumor Marker Test Volume Forecast
Japan, Total Tumor Marker Sales
Forecast by Market Segment
Japan, All Market Segments Major Tumor
Marker Sales Forecast by Test
Japan, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
Japan, Commercial/Private Laboratories Major
Tumor Marker Sales Forecast by Test
Japan, ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Beta2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, CA 153/27.29 Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, CA 199 Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, CA125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, CEA Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Chromogranin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, ColonSpecific Antigen Test Volume
And Diagnostics Sales Forecast by Market
Segment
Japan, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Ferritin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Gastrin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, HCG Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Interferons Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Interleukins Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, NSE Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Nucleolar Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, S100 Protein Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Serotonin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, TPA, Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Total Tumor Marker
Sales by Major Supplier
Japan, AFP Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 153/27.29 Testing Market
Diagnostics Sales by Major Supplier
Japan, CA 199 Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics
Sales by Major Supplier
Japan, CEA Testing Market Diagnostics
Sales by Major Supplier
Japan, NSE Testing Market Diagnostics
Sales by Major Supplier
Japan, PAP Testing Market Diagnostics
Sales by Major Supplier
Japan, PSA Testing Market Diagnostics
Sales by Major Supplier
Japan, Tumor Marker Testing
Instrumentation, Major System
Estimated Placements and Installed Base
By Supplier and Model
Executive Summary Table: Spain, Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment
Spain, Estimated Cancer Death Rates
Per 100,000 Population
Spain, Laboratories Performing Tumor
Marker Tests by Market Segment
Spain, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Spain, Commercial/Private Laboratories
Performing Tumor Markers by
Annual Test Volume
Spain, Total Tumor Marker Test Volume
Forecast by Market Segment
Spain, All Market Segment Major Cancer
Diagnostic Test Volume Forecast
Spain, Hospital Laboratories Major Cancer
Diagnostic Test Volume Forecast by
Test
Spain, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Spain, Total Tumor Marker Sales
Forecast by Market Segment
Spain, All Market Segments Major Tumor
Marker Sales Forecast by Test
Spain, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
Spain, Commercial/Private Laboratories Major
Tumor Marker Sales Forecast by Test
Spain, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, Beta2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
Spain, CA 153 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CA 199 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CA125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, ColonSpecific Antigen Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Lymphocyte Subtyping
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Parathyroid Hormone Test Volume
And Diagnostics Sales Forecast by Market
Segment
Spain, Progesterone Receptor
Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain, PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, S100 Protein Test Volume
And Diagnostics Sales Forecast by Market
Segment
Spain, Serotonin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Total Tumor Marker Sales by
Major Supplier
Spain, AFP Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 153/27.29 Testing Market
Diagnostics Sales by Major Supplier
Spain, 199 Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Spain, CEA Testing Market Diagnostics
Sales by Major Supplier
Spain, PSA Testing Market Diagnostics
Sales by Major Supplier
Spain, Tumor Marker Testing Instrumentation
Major Systems Estimated Placements and
Installed Base by Supplier and Model
Executive Summary Table: U.K., Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment
U.K., Estimated Cancer Death Rates
Per 100,000 Population
U.K., Laboratories Performing Tumor
Marker Tests by Market Segment
U.K., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.K., Commercial/Private Laboratories
Performing Tumor Marker Tests by
Annual Test Volume
U.K., Total Tumor Marker Testing Volume
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Test Volume Forecast
U.K., Hospital Laboratories Major
Tumor Marker Test Volume Forecast by
Assay
U.K., Commercial/Private Laboratories
Major Tumor Marker Test Volume
Forecast
U.K., Total Tumor Marker Sales
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Sales Forecast by Test
U.K., Hospital Laboratories Major
Tumor Marker Sales Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by
Test
U.K., ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K., AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K., Beta2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., CA 153/27.29 Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., CA 199 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., CA125 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Calcitonin Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., CEA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., ColonSpecific Antigen Test Volume
And Diagnostics Sales by Market
Segment
U.K., Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Ferritin Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Oncogenes Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PAP Smear Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., S100 Protein Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Serotonin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Total Tumor Marker Sales and
Market Shares Forecast
U.K., CEA Testing Market Diagnostics
Sales by Major Supplier
U.K., PSA Testing Market Diagnostics
Sales by Major Supplier
U.K., Tumor Marker Testing
Instrumentation Major Systems
Estimated Placements and Installed Base
By Supplier and Model
Executive Summary Table: U.S., Total Tumor
Marker Test Volume and Sales Forecast by
Market Segment
U.S., Estimated New Cancer Cases and Deaths
U.S., Estimated Cancer Death Rates
Per 100,000 Population
U.S., Laboratories Performing Tumor
Marker Tests by Market Segment
U.S., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.S., Commercial/Private Laboratories
Performing Tumor Marker Tests by
Annual Test Volume
U.S., Physician Office Laboratories
Performing Tumor Marker Tests by
Practice Size
U.S., Total Tumor Marker Test Volume
Forecast by Market Segment
U.S., All Market Segments Major
Tumor Marker Test Volume Forecast
U.S., Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
U.S., Commercial/Private Laboratories
Major Tumor Marker Test Volume
Forecast
U.S., Physician Offices/Group Practices
Major Tumor Marker Test Volume
Forecast
U.S., Cancer Clinics Major Tumor
Marker Test Volume Forecast by Assay
U.S., Total Tumor Marker Sales
Forecast by Market Segment
U.S., All Market Segment Major Tumor
Marker Sales Forecast by Test
U.S., Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
U.S., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
U.S., Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
U.S., Cancer Clinics Major Tumor
Marker Sales Forecast by Test
U.S., ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Beta2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., CA 153/27.29 Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., CA 199 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., CA125 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Calcitonin Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., CEA Test Volume and Diagnostics
Sales by Market Segment
U.S., Chromogranin Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Colonspecific Antigen Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Interferons Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Interleukins Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Oncogenes Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., PAP Smear Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., S100 Protein Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.S., Serotonin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Sialic Acid Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Thyroglobulin Test
Volume and Diagnostics
Sales Forecast by Market Segment
U.S., TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Total Tumor Marker Sales
By Major Supplier
U.S., AFP Testing Market Diagnostics
Sales by Major Supplier
U.S., CA 125 Testing Market Diagnostics
Sales by Major Supplier
U.S., CA 153/27.29 Testing Market
Diagnostics Sales by Major Supplier
U.S., CEA Testing Market Diagnostics
Sales by Major Supplier
U.S., Ferritin Testing Market
Diagnostics Sales by Major Supplier
U.S., HCG Testing Market
Diagnostics Sales by Major Supplier
U.S., Insulin Testing Market
Diagnostics Sales by Major Supplier
U.S., PAP Testing Market Diagnostics
Sales by Major Supplier
U.S., PSA Testing Market Diagnostics
Sales by Major Supplier
U.S., Tumor Marker Testing Instrumentation
Major Systems Estimated Placements and
Installed Base by Supplier and Model

Published By: Venture Planning Group
Product Code: Venture Planning Group439


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100